Predictive factors for successful imatinib cessation in chronic myeloid leukemia patients treated with imatinib
2013 · American Journal of Hematology · 56 citations
https://doi.org/10.1002/ajh.23427
Y
Yun Jeong Oh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
272
Citations
9
h-index
7
i10-index
Yun Jeong Oh is an academic researcher. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Eosinophilic Disorders and Syndromes. The author has an h-index of 9, co-authored 19 publications.
Papers by this author
worksResults From The Korean Imatinib Discontinuation Study (KIDS): Updated Data With 14-Month Median Follow Up
2013 · Blood · 8 citations
https://doi.org/10.1182/blood.v122.21.4003.4003
Nilotinib Or High-Dose Imatinib Compared With Standard-Dose Imatinib In Early Chronic Phase CML Patients Who Have Suboptimal Molecular Responses To Standard-Dose Imatinib: Including Updated Data From RE-Nice Study
2013 · Blood · 4 citations
https://doi.org/10.1182/blood.v122.21.1499.1499
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat